Figure S1 from A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma
crossref(2023)
摘要
Figure S1 shows ASTX660 dose proportionality-power model analyses on AUC0-24 and Cmax by formulation.
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要